Tauriga Sciences Inc. Appoints Mr. Alan H. Vicory Jr. PE, BCEE as the Fourth Member of Company's Scientific Advisory Board

        Print
| Source: Tauriga Sciences Inc

CINCINNATI, March 18, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license agreements, topical medicinal cannabis lotions, and a proprietary technology platform in the nanorobotics space, has today announced the appointment of Mr. Alan H. Vicory Jr. PE, BCEE ("Mr. Vicory") as the fourth member of the company's scientific advisory board. Mr. Vicory currently is a principal in the Cincinnati, Ohio office of Stantec Inc. (NYSE:STN) where he is leading regulatory interface, watershed planning and water quality initiatives throughout the Southeast region of the United States. The expertise and industry contacts that Mr. Vicory brings to the table will be extremely valuable to the Company as it prepares to launch the commercial pilot tests of its proprietary microbial based fuel cell technology ("Electrogenic Bioreactor" or "EBR"). As previously mentioned, the Company expects its initial two customers to include: The Metropolitan Sewer District of Greater Cincinnati ("MSDGC") and a large international beverage company.  

Commenting on his appointment, Mr. Vicory stated, "After much careful review of Pilus Energy's technology platform, I have concluded that the technology is cutting edge and there is a legitimate market opportunity for Tauriga. As a top engineering firm in the wastewater treatment sector, my firm is looking forward to providing Tauriga with the technical expertise to successfully complete its upcoming commercial pilot tests. Additionally I strongly believe that Tauriga's management is making the right decisions to be successful in this fast growing industry."

Tauriga's CEO Dr. Stella M. Sung commented, "The company is pleased to have Mr. Vicory join its scientific advisory board as his knowledge base and world class experience are important assets to the Company moving forward. The Company has recently made significant progress in its commercialization efforts of Pilus Energy's technology platform for the treatment of industrial and municipal wastewater. The addition of Mr. Vicory to the scientific advisory board and the ability to work with his firm Stantec are two important puzzle pieces that have now been assembled into the Company's foundation."

Personal BIO for Alan H. Vicory Jr. PE, BCEE., age 62

Mr. Vicory is a Principal in Stantec Inc.'s Cincinnati, Ohio office where he is leading regulatory interface, watershed planning and water quality initiatives throughout the Southeast region. Recognized as a national and international leader on water quality and water resource management issues, Mr. Vicory has extensive experience in these specialized areas, cultivated during his nearly 30 years of work in the industry. The past 24 years, he served as the Executive Director and Chief Engineer of ORSANCO, an eight-state agency established to control and abate water pollution in the Ohio Basin. During that time, Mr. Vicory guided its transition to an agency with enhanced program capacity and one which was active and influential in national policy development through strong relationships with US Environmental Protection Agency and Congress.

Mr. Vicory has served as Chairman of the "Confluence" Water Technology Innovation Cluster (WTIC Confluence) since its establishment in January 2011 where he has helped guided its rapid development as an important organizational asset to the Ohio-Kentucky-Indiana Region.

Mr. Vicory graduated from the Virginia Military Institute ("VMI") class of 1974 with a B.S. in Civil Engineering. In addition Mr. Vicory was the past President of both the American Academy of Environmental Engineers and Association of State and Interstate Water Pollution Control Administrators. He is also a Past Chairman of the Water Environment Research Foundation (WERF)

On March 10, 2014, Tauriga Sciences signed a Definitive Agreement to Acquire California's Leading Manufacturer of Topical and Medicinal Cannabis Based Therapeutic Creams. The Cannabis Manufacturer has developed both an extensive line of medicinal cannabis products as well as delivery technologies. This unique product line of topical cannabis creams ("cream" or "lotion" or "topical cannabis products") deliver the pain relieving and healing power of cannabis right where its applied and is quickly absorbed through the epidermis, with nearly immediate results that last for hours without psychoactive side effects. Founded in 2009 this Cannabis Manufacturer, with which Tauriga entered into the definitive agreement, is a revenue generating company whose products can be found in more than 100 dispensaries within the State of California. This definitive agreement is in effect for a period of 120 days (from the date of signing) and both parties are working diligently to complete the transaction.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. The Company's corporate website can be found at (www.tauriga.com).

DISCLAIMER:

Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

Tauriga Sciences, Inc.:
Dr. Stella M. Sung
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
www.tauriga.com
San Diego: + 1-858-353-5749
Montreal: + 1-514-840-3697
Email: